Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Now the results of a new study suggest that clinical trials for new rheumatoid arthritis (RA) drugs should shift from their sole focus on relieving inflammation to eliminating the B cells that produce these antibodies.
A specific gene that helps form memories from traumatic events can be manipulated – and in doing so may actually help prevent post-traumatic stress disorder (PTSD), according to a new study led NYU Langone Medical Center.
In a concerted effort to help address the unique and complex needs of patients with headaches and migraines, NYU Langone has recruited nationally renowned expert Lawrence Newman, MD, to serve as its new director of the division of Headache Medicine division and as professor (clinical) in the Department of Neurology, where he will lead research and clinical efforts to combat these conditions that can drastically affect a patient’s quality of life.
Theodore H. Welling, III, MD, will lead a new state-of-the-art liver cancer program at NYU Langone to advance clinical care and accelerate the translation of lab breakthroughs into superior treatments.
The diversity of Brooklyn’s population has transformed the practice of infectious diseases that is akin to global medicine at NYU Lutheran Medical Center.
The pediatric neuropsychology program at NYU Lutheran, led by Gianna Locascio, PsyD, brings a new level of care to Brooklyn families.
Scientists at NYU Langone Medical Center have discovered the mechanisms behind a genetic change known to cause a set of related diseases.
Responding to demands from cities across the country, NYU School of Medicine’s Department of Population Health, NYU’s Robert F. Wagner School of Public Service, and the National Resource Network, with support from the Robert Wood Johnson Foundation, are launching the City Health Dashboard. The online data visualization tool will greatly improve city-level understanding of health and empower mayors, city managers, health officials, and other local stakeholders to enact policies that target the risk factors and health conditions that most impact their communities.
Perlmutter Cancer Center at NYU Langone Medical Center is again joining with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to increase vaccination against the human papillomavirus (HPV).
Millions of Americans suffer each year from ailments of the ears, nose and throat (ENT)—with a significant number occurring in children and adolescents. NYU Lutheran Medical Center is addressing these problems head on for families in Brooklyn through an expanded ENT program under the auspices of the nationally ranked Otolaryngology (ENT) Department at NYU Langone Medical Center.
NYU Langone Medical Center has announced that internationally recognized surgeon and scientist Diane M. Simeone, MD, will join its Perlmutter Cancer Center on March 1 to serve as associate director for translational research and to lead its newly established pancreatic cancer center.
Dan Iofifescu, MD, MSc, a clinician-scientist specializing in mood disorders, has been recruited to the Psychiatry faculty at NYU Langone Medical Center, furthering the department’s national reputation in diagnosing and managing depression and related disorders.
Elizabeth Hammer, MD, has been appointed director of the Sunset Park, Brooklyn, medical center's dialysis unit. Dr. Hammer, a highly trained nephrologist, will lead the unit's expansion and emphasize patient safety and quality.
Naomi Michele Simon, MD, MSc, a world renowned expert in complicated grief and anxiety disorders, is joining the faculty of NYU Langone's Department of Psychiatry to spearhead a new initiative into these illnesses.
The combination of two new drugs that harness the body’s immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.
When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.
NYU Langone receives $15 million for a five-year research grant from the National Eye Institute to evaluate treatment for shingles of the eye.
Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone’s Perlmutter Cancer Center, has received a 2016 “Giants of Cancer Care” Award, presented by OncLive, a professional organization for oncologists.
At NYU Lutheran Medical Center and hospitals nationwide, a new team of doctors called “hospitalists” have become a regular presence, specially trained to deliver comprehensive care to inpatients.
The newly implemented emergency department care model at NYU Lutheran Medical Center has introduced a new model of care to improve efficiency and provide a better patient experience.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right